IP Library Granted Patent US 7,621,954
Granted Patent B2
US 7,621,954 · App. 11/635,928 · Granted Nov 24, 2009

In situ bioprosthetic filler and methods, particularly for in situ formation of vertebral disc bioprosthetics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,621,954
App. No.
11/635,928
Granted
Nov 24, 2009
Kind
B2
Abstract

Bioprosthetic devices include an exterior biological tissue member which at least partly defines a cavity, and a proteinaceous biopolymer which fills the cavity, and intercalates and is chemically bound (fixed) to the tissue of the surrounding biological tissue member. In preferred forms, the bioprosthetic device is a bioprosthetic vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity and is formed by removal of at least a substantial portion of the natural gelatinous core therefrom. The cavity defined by the fibrillar outer annulus may then be filled with a flowable proteinaceous biopolymer. Preferably, the proteinaceous biopolymer is a liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde, which are allowed to react in situ to form a cross-linked biopolymer within the cavity. The liquid mixture may be formed in advance of being introduced into the cavity, or may be formed simultaneously during introduction into the cavity.

Claims (19)

1. A compressible prosthetic core for a vertebral disc having a cavity bound by a fibrillar outer annulus, the cavity being formed by the removal of the vertebral disc's natural gelatinous core comprising:

a proteinaceous biopolymeric material comprising a cross-linked reaction product of human or animal-derived protein material and a di- or polyaldehyde the proteinaceous biopolymeric material being load distributing and compressible without exhibiting substantial deformation and being dimensioned to fill the cavity of the vertebral disc.

2. The compressible prosthetic core of claim 1 , wherein the proteinaceous biopolymeric material further comprises a fibrous or particulate filler material.

3. The compressible prosthetic core of claim 1 , wherein the protein comprises bovine or human serum albumin or hemoglobin.

4. The compressible prosthetic core of claim 1 , wherein the aldehyde comprises glutaraldehyde.

5. The compressible prosthetic core of claim 1 , wherein when the biopolymeric material is provided within the cavity of the vertebral disc, the vertebral disc remains intact and flexible after being subjected to 5 million cycles of a cyclic load of 0.85 MPa.

6. The compressible prosthetic core of claim 1 , wherein the proteinaceous biopolymeric material is configured to chemically bind to the tissue of the vertebral disc.

7. A compressible prosthetic core for a vertebral disc having an exterior biological tissue member which at least partly defines a cavity comprising:

a proteinaceous biopolymeric material which is dimensioned to fill the cavity of the vertebral disc;

wherein the proteinaceous biopolymeric material is the reaction product of at least two reactable components and is load distributing and compressible without exhibiting substantial permanent deformation, and one of the components comprises human or animal-derived serum albumin or hemoglobin.

8. The compressible prosthetic core of claim 7 , wherein the proteinaceous biopolymeric material further comprises a fibrous or particulate filler material.

9. The compressible prosthetic core of claim 7 , wherein the vertebral disc exhibits flexibility comparable to the biologically natural vertebral disc after being subjected to 5 million cycles of cyclic load of 0.85 MPa when the compressible prosthetic core is provided in the cavity of vertebral disc.

10. The compressible prosthetic core of claim 7 , wherein the proteinaceous biopolymeric material is configured to chemically bind to the tissue of the vertebral disc.

11. The compressible prosthetic core of claim 8 , wherein the proteinaceous biopolymeric material is configured to chemically bind to the tissue of the vertebral disc.

12. A compressible prosthetic core for a vertebral disc having a fibrillar outer annulus which remains following removal of a gelatinous core from a biologically natural vertebral disc to thereby define an interior cavity comprising:

a proteinaceous biopolymeric material which is dimensioned to fill the interior cavity of the vertebral disc,

the proteinaceous biopolymeric material being the reaction product of at least two reactable components, one of which comprises human or animal-derived serum albumin or hemoglobin,

wherein the proteinaceous biopolymeric material is capable of withstanding compression for 100 and 1000 cycles at a compression rate of 100 mm/min between a minimum stress of 200 kPa and a maximum stress of 800 kPa without exhibiting fracture, permanent deformation, and loss of hydration, and

wherein the vertebral disc is capable of withstanding a constant load of 700 N for 10 minutes when the proteinaceous biopolymeric material is provided in the interior cavity of the vertebral disc.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 22, 2024
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC.
Reel/Frame 066360/0562 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2017
From: CRYOLIFE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.)
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044616/0940 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Dec 1, 2017
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT
To: CRYOLIFE, INC.; CRYOLIFE ACQUISITION CORPORATION; CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.); HEMOSPHERE, INC.; ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.); VALVE SPECIAL PURPOSE CO., LLC
Reel/Frame 044621/0240 →
SECURITY INTEREST Recorded Jan 21, 2016
From: CRYOLIFE, INC., AS GRANTOR; VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR; ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT
Reel/Frame 037569/0212 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 19, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037146/0466 →